Search
Browse
Statistics
Feeds

Browse by Research Team

Group by: Date | Item Type | Source
Jump to: American Journal of Hematology | Analytical Chemistry | Annals of the New York Academy of Sciences | Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts | Apoptosis, Cell Signaling, and Human Diseases | Biochimica et Biophysica Acta - Reviews on Cancer | Blood | Blood Cancer Discovery | Blood Cells Molecules and Diseases | Breast Cancer Research | British Journal of Cancer | Cancer Cell | Cancer Discovery | Cancer Gene Therapy | Cancer Research | Cancers | Cell | Cell Death Discovery | Cellular and Molecular Biology Letters | Cellular and Molecular Neurobiology | Critical Care Research and Practice | Current Opinion in Genetics & Development | EMBO Journal | European Journal of Immunology | Genes & Development | Gut | HemaSphere | International Journal of Cancer | International Journal of Hematologic Oncology | Journal of Clinical Investigation | Journal of Clinical Medicine | Journal of Experimental Medicine | Journal of Molecular Medicine | Journal of Rheumatology | Journal of Visualized Experiments | Journal of the National Cancer Institute | Leukemia | Leukemia & Lymphoma | Methods in Molecular Biology | Molecular Cancer Therapeutics | Molecular Genetics & Genomic Medicine | Molecules and Cells | Nature | Nature Cancer | Nature Cell Biology | Nature Communications | Nature Reviews Cancer | Nature Reviews Clinical oncology | Nature Reviews Immunology | Neuro-Oncology | Oncogene | Oncology | Oncotarget | PLoS Biology | PLoS ONE | Rapid Communications in Mass Spectrometry | Recent Results in Cancer Research | Research Square | Seminars in Cancer Biology | Theranostics | Therapeutic Advances in Medical Oncology | Transplantation | Trends in Cell Biology | bioRxiv | iScience | memo: Magazine of European Medical Oncology

American Journal of Hematology

Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine - a prospective cohort study by the AGMT.
Pleyer, L. ORCID logoORCID: https://orcid.org/0000-0002-2790-5067, Vaisband, M., Drost, M., Pfeilstöcker, M., Stauder, R., Heibl, S., Sill, H. ORCID logoORCID: https://orcid.org/0000-0003-0993-4371, Girschikofsky, M., Stampfl-Mattersberger, M., Pichler, A., Hartmann, B., Petzer, A., Schreder, M., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Vallet, S., Melchardt, T., Zebisch, A., Pichler, P., Zaborsky, N., Machherndl-Spandl, S., Wolf, D., Keil, F., Hasenauer, J., Larcher-Senn, J. and Greil, R.
American Journal of Hematology 98 (11): 1685-1698. November 2023

ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Mondello, P. ORCID logoORCID: https://orcid.org/0000-0002-0355-3757, Musolino, C., Dogliotti, I., Bohn, J.P. ORCID logoORCID: https://orcid.org/0000-0002-2066-7377, Cavallo, F., Ferrero, S., Botto, B., Cerchione, C., Nappi, D., De Lorenzo, S., Martinelli, G., Wolf, D., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Loseto, G., Cuzzocrea, S., Willenbacher, W., Mian, M. ORCID logoORCID: https://orcid.org/0000-0003-2539-5996 and Straus, D.J.
American Journal of Hematology 95 (9): 1030-1037. September 2020

Analytical Chemistry

Nontargeted identification of tracer incorporation in high-resolution mass spectrometry.
Hoffmann, F., Jaeger, C., Bhattacharya, A. ORCID logoORCID: https://orcid.org/0000-0003-3733-7670, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lisec, J.
Analytical Chemistry 90 (12): 7253-7260. 19 June 2018

Automated annotation and evaluation of in-source mass spectra in GC/atmospheric pressure chemical ionization-MS-based metabolomics.
Jaeger, C., Hoffmann, F., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lisec, J.
Analytical Chemistry 88 (19): 9386-9390. 4 October 2016

Extending the dynamic range in metabolomics experiments by automatic correction of peaks exceeding the detection limit.
Lisec, J., Hoffmann, F., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Jaeger, C.
Analytical Chemistry 88 (15): 7487-7492. 2 August 2016

Annals of the New York Academy of Sciences

Cancer stem cells: advances in biology and clinical translation -- a Keystone Symposia report.
Cable, J., Pei, D., Reid, L.M., Wang, X.W., Bhatia, S., Karras, P., Melenhorst, J.J., Grompe, M., Lathia, J.D., Song, E., Kuo, C.J., Zhang, N., White, R.M., Ma, S.K., Ma, L., Chin, Y.R., Shen, M.M., Ng, I.O.L., Kaestner, K.H., Zhou, L., Sikandar, S., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Guo, W., Wong, C.C.L., Ji, J., Tang, D.G., Dubrovska, A., Yang, C., Wiedemeyer, W.R. and Weissman, I.L.
Annals of the New York Academy of Sciences 1506 (1): 142–163. December 2021

Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts

Mouse models in cancer research.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
In: Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts. UNSPECIFIED, 671-701. ISBN 9783527312375 6 February 2006

Apoptosis, Cell Signaling, and Human Diseases

Apoptosis and cancer therapy.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
In: Apoptosis, Cell Signaling, and Human Diseases. Humana Press, 303-320. ISBN 978-1-58829-677-1 2007

Biochimica et Biophysica Acta - Reviews on Cancer

Cellular senescence and cancer treatment.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Biochimica et Biophysica Acta - Reviews on Cancer 1775 (1): 5-20. January 2007

Blood

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
Wilke, A.C., Doebele, C., Zindel, A., Lee, K.S. ORCID logoORCID: https://orcid.org/0000-0001-7682-5736, Rieke, S.A. ORCID logoORCID: https://orcid.org/0000-0002-2890-1308, Ceribelli, M., Comoglio, F. ORCID logoORCID: https://orcid.org/0000-0002-8970-6610, Phelan, J.D., Wang, J.Q., Pikman, Y., Jahn, D., Häupl, B., Schneider, C., Scheich, S., Tosto, F.A., Bohnenberger, H. ORCID logoORCID: https://orcid.org/0000-0003-1038-1030, Stauder, P. ORCID logoORCID: https://orcid.org/0000-0002-3876-6023, Schnütgen, F. ORCID logoORCID: https://orcid.org/0000-0002-2426-6685, Slabicki, M., Coulibaly, Z.A., Wolf, S., Bojarczuk, K., Chapuy, B. ORCID logoORCID: https://orcid.org/0000-0002-6485-8773, Brandts, C.H. ORCID logoORCID: https://orcid.org/0000-0003-1732-2535, Stroebel, P. ORCID logoORCID: https://orcid.org/0000-0002-8528-8060, Lewis, C.A., Engelke, M., Xu, X. ORCID logoORCID: https://orcid.org/0000-0003-1062-2092, Kim, H., Dang, T.H., Schmitz, R. ORCID logoORCID: https://orcid.org/0000-0002-3348-6807, Hodson, D.J. ORCID logoORCID: https://orcid.org/0000-0001-6225-2033, Stegmaier, K., Urlaub, H., Serve, H. ORCID logoORCID: https://orcid.org/0000-0001-8472-5516, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Kreuz, F., Knittel, G. ORCID logoORCID: https://orcid.org/0000-0001-8395-3701, Rabinowitz, J.D. ORCID logoORCID: https://orcid.org/0000-0002-1247-4727, Reinhardt, H.C., Vander Heiden, M.G., Thomas, C., Staudt, L.M., Zenz, T. and Oellerich, T. ORCID logoORCID: https://orcid.org/0000-0001-6570-6125
Blood 139 (4): 538-553. 27 January 2022

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Schrezenmeier, J.F. ORCID logoORCID: https://orcid.org/0000-0001-5239-4513, Richter-Pechanska, P. ORCID logoORCID: https://orcid.org/0000-0001-6727-6317, Dolnik, A., Hick, T.P., Schleich, K., Cai, X., Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076, Lohneis, P., Masswig, S., Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019, Busse, A. ORCID logoORCID: https://orcid.org/0000-0002-3470-6947, Knittel, G., Flümann, R., Childs, D., Childs, L., Gätjens-Sanchez, A.M., Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510, Rosenwald, A., Reinhardt, H.C. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Blood 137 (20): 2785-2899. 20 May 2021

Initiation of acute graft-versus-host disease by angiogenesis.
Riesner, K., Shi, Y., Jacobi, A., Kräter, M., Kalupa, M., McGearey, A., Mertlitz, S., Cordes, S., Schrezenmeier, J.F. ORCID logoORCID: https://orcid.org/0000-0001-5239-4513, Mengwasser, J., Westphal, S., Perez-Hernandez, D. ORCID logoORCID: https://orcid.org/0000-0003-0266-9050, Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Dittmar, G. ORCID logoORCID: https://orcid.org/0000-0003-3647-8623, Guck, J. and Penack, O.
Blood 129 (14): 2021-2032. 6 April 2017

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma.
Du, J., Neuenschwander, M. ORCID logoORCID: https://orcid.org/0000-0002-3114-7975, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Däbritz, J.H.M., Neuendorff, N.R., Schleich, K., Bittner, A. ORCID logoORCID: https://orcid.org/0000-0001-6434-0950, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Beuster, G., Radetzki, S. ORCID logoORCID: https://orcid.org/0000-0003-2688-2868, Specker, E. ORCID logoORCID: https://orcid.org/0000-0002-9471-9520, Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Rosenbauer, F. ORCID logoORCID: https://orcid.org/0000-0001-7977-9421, Mathas, S. ORCID logoORCID: https://orcid.org/0000-0001-9626-1413, Lohneis, P., Hummel, M., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, von Kries, J.P. ORCID logoORCID: https://orcid.org/0000-0003-4716-4988, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Blood 129 (1): 71-81. 5 January 2017

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
Mansouri, L., Noerenberg, D., Young, E., Mylonas, E., Abdulla, M., Frick, M., Asmar, F., Ljungstroem, V., Schneider, M., Yoshida, K., Skaftason, A., Pandzic, T., Gonzalez, B., Tasidou, A., Waldhueter, N., Rivas-Delgado, A., Angelopoulou, M., Ziepert, M., Arends, C.M., Couronne, L., Lenze, D., Baldus, C.D., Bastard, C., Okosun, J., Fitzgibbon, J., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Drexler, H.G., Roos-Weil, D., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Munch-Petersen, H.D., Zenz, T., Hansmann, M.L., Strefford, J.C., Enblad, G., Bernard, O.A., Ralfkiaer, E., Erlanson, M., Korkolopoulou, P., Hultdin, M., Papadaki, T., Gronbaek, K., Lopez-Guillermo, A., Ogawa, S., Kueppers, R., Stamatopoulos, K., Stavroyianni, N., Kanellis, G., Rosenwald, A., Campo, E., Amini, R.M., Ott, G., Vassilakopoulos, T.P., Hummel, M., Rosenquist, R. and Damm, F.
Blood 128 (23): 2666-2670. 15 December 2016

B cell-specific conditional expression of Myd88(p.L252P) leads to the development of diffuse large B cell lymphoma in mice.
Knittel, G., Liedgens, P., Korovkina, D., Seeger, J.M., Al-Baldawi, Y., Al-Maarri, M., Fritz, C., Vlantis, K., Bezhanova, S., Scheel, A.H., Wolz, O.O., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Möller, P., López, C., Schlesner, M., Lohneis, P., Weber, A.N.R., Trümper, L., Staudt, L.M., Ortmann, M., Pasparakis, M., Siebert, R., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Klatt, A.R., Wunderlich, F.T., Schäfer, S.C., Persigehl, T., Montesinos-Rongen, M., Odenthal, M., Büttner, R., Frenzel, L.P., Kashkar, H. and Reinhardt, H.C.
Blood 127 (22): 2732-2741. 2 June 2016

Combined inhibition of PI3K-related DNA-damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.
Shortt, J., Martin, B.P., Newbold, A., Hannan, K.M., Devlin, J.R., Baker, A.J., Ralli, R., Cullinane, C., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Hall, M.N., Wall, M., Hannan, R.D., Pearson, R.B., McArthur, G.A. and Johnstone, R.W.
Blood 121 (15): 2964-2974. 11 April 2013

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Blood 110 (8): 2996-3004. 15 October 2007

Blood Cancer Discovery

An autochthonous mouse model of Myd88- and BCL2-driven diffuse large B-cell lymphoma reveals actionable molecular vulnerabilities.
Flümann, R., Rehkämper, T., Nieper, P., Pfeiffer, P., Holzem, A., Klein, S., Bhatia, S., Kochanek, M., Kisis, I., Pelzer, B.W., Ahlert, H., Hauer, J., da Palma Guerreiro, A., Ryan, J.A., Reimann, M., Riabinska, A., Wiederstein, J., Krüger, M., Deckert, M., Altmüller, J. ORCID logoORCID: https://orcid.org/0000-0003-4372-1521, Klatt, A.R., Frenzel, L.P., Pasqualucci, L., Béguelin, W., Melnick, A.M., Sander, S., Montesinos-Rongen, M., Brunn, A., Lohneis, P., Büttner, R., Kashkar, H., Borkhardt, A., Letai, A., Persigehl, T., Peifer, M., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Reinhardt, H.C. and Knittel, G.
Blood Cancer Discovery 2 (1): 70-91. January 2021

Blood Cells Molecules and Diseases

Daratumumab as a novel treatment option in refractory ITP.
Vernava, I. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Blood Cells Molecules and Diseases 99 : 102724. March 2023

Breast Cancer Research

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
Gampenrieder, S.P., Rinnerthaler, G., Tinchon, C., Petzer, A., Balic, M., Heibl, S., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Zabernigg, A.F., Egle, D., Sandholzer, M., Singer, C.F., Roitner, F., Hager, C., Andel, J., Hubalek, M., Knauer, M. and Greil, R. ORCID logoORCID: https://orcid.org/0000-0002-4462-3694
Breast Cancer Research 23 (1): 112. 14 December 2021

British Journal of Cancer

Cellular senescence predicts treatment outcome in metastasised colorectal cancer.
Haugstetter, A.M., Loddenkemper, C., Lenze, D., Groene, J., Standfuss, C., Petersen, I., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
British Journal of Cancer 103 (4): 505-509. 10 August 2010

Cancer Cell

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer.
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Ghanem, R., Stegemann, M., Klein, K., Pammer, M., Rauscher, I., Salzer, H.J.F., Doppler, S., Habringer, A., Paar, C., Kimeswenger, S., Hoetzenecker, W., Lamprecht, B., Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancer Cell 39 (9): 1171-1172. 13 September 2021

UnSASPing senescence: unmasking tumor suppression?
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancer Cell 34 (1): 6-8. 9 July 2018

Targeting the senescence-overriding cooperative activity of structurally unrelated H3K9 demethylases in melanoma.
Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M.S., Qutob, N., van Rooijen, E., Werner-Klein, M., Li, L., Dhawan, D. ORCID logoORCID: https://orcid.org/0000-0003-3005-7772, Meierjohann, S., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Elkahloun, A., Treitschke, S., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Speck, C., Mallette, F.A., Zon, L.I., Holmen, S.L., Peeper, D.S., Samuels, Y., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931
Cancer Cell 33 (2): 322-336. 12 February 2018

Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Bywater, M.J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C., Wall, M., Cluse, L., Drygin, D., Anderes, K., Huser, N., Proffitt, C., Bliesath, J., Haddach, M., Schwaebe, M.K., Ryckman, D.M., Rice, W.G., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Lowe, S.W., Johnstone, R.W., Pearson, R.B., McArthur, G.A. and Hannan, R.D.
Cancer Cell 22 (1): 51-65. 10 July 2012

Tumor stroma-derived TGF-beta limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Loddenkemper, C., Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Tabor, V., Aichele, P., Stein, H., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Jenuwein, T. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancer Cell 17 (3): 262-272. 16 March 2010

Cancer Discovery

Passenger gene coamplifications create collateral therapeutic vulnerabilities in cancer.
Bei, Y. ORCID logoORCID: https://orcid.org/0000-0002-2104-8025, Brame, Luca ORCID logoORCID: https://orcid.org/0000-0001-5316-2992, Kirchner, M. ORCID logoORCID: https://orcid.org/0000-0002-7049-534X, Fritsche-Guenther, R. ORCID logoORCID: https://orcid.org/0000-0002-6965-0226, Kunz, S. ORCID logoORCID: https://orcid.org/0000-0002-0131-3506, Bhattacharya, A. ORCID logoORCID: https://orcid.org/0000-0003-3733-7670, Rusu, M.C. ORCID logoORCID: https://orcid.org/0000-0002-8369-3580, Gürgen, D. ORCID logoORCID: https://orcid.org/0000-0001-9241-6537, Dubois, F.P.B. ORCID logoORCID: https://orcid.org/0000-0002-7654-6208, Köppke, J.K.C. ORCID logoORCID: https://orcid.org/0000-0002-1293-7250, Proba, J. ORCID logoORCID: https://orcid.org/0009-0006-8293-1248, Wittstruck, N. ORCID logoORCID: https://orcid.org/0009-0000-4378-3226, Sidorova, O.A. ORCID logoORCID: https://orcid.org/0009-0004-1459-1662, Chamorro González, R. ORCID logoORCID: https://orcid.org/0000-0002-5653-7259, Dorado Garcia, H. ORCID logoORCID: https://orcid.org/0000-0002-2578-3350, Brückner, L. ORCID logoORCID: https://orcid.org/0000-0002-6155-2277, Xu, R. ORCID logoORCID: https://orcid.org/0000-0002-5618-246X, Giurgiu, M. ORCID logoORCID: https://orcid.org/0000-0001-5007-7442, Rodriguez-Fos, E. ORCID logoORCID: https://orcid.org/0000-0002-2555-0178, Yu, Q. ORCID logoORCID: https://orcid.org/0000-0002-2151-9624, Spanjaard, B. ORCID logoORCID: https://orcid.org/0000-0003-1309-8839, Koche, R.P. ORCID logoORCID: https://orcid.org/0000-0002-6820-5083, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Schulte, J.H. ORCID logoORCID: https://orcid.org/0000-0003-0671-1201, Eggert, A. ORCID logoORCID: https://orcid.org/0000-0003-3476-8184, Haase, K. ORCID logoORCID: https://orcid.org/0000-0002-0944-5618, Kirwan, J. ORCID logoORCID: https://orcid.org/0000-0002-5423-1651, Hagemann, A.I. ORCID logoORCID: https://orcid.org/0000-0001-5491-4607, Mertins, P. ORCID logoORCID: https://orcid.org/0000-0002-2245-528X, Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548 and Henssen, A.G. ORCID logoORCID: https://orcid.org/0000-0003-1534-778X
Cancer Discovery 14 (3): 492-507. 1 March 2024

Cancer Gene Therapy

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model.
Wang, F., Zhang, S., Sun, F., Chen, W., Liu, C., Dong, H., Cui, B., Li, L., Sun, C., Du, W., Liu, B., Fan, W., Deng, J., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Wang, X. and Du, J.
Cancer Gene Therapy 31 (8): 1135-1150. August 2024

Cancer Research

Chronic stress stimulates protumor macrophage polarization to propel lung cancer progression.
Liu, Cuilan, Du, Hengwei, Yu, Guoxing, Qi, Jingjing, Dong, Hongliang, Hu, Ruiqi, Wang, Fei, Cui, Bingjie, Chen, Weiwei, Zhang, Qian, Li, Chen, Gao, Ran, Schmitt, Clemens A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Deng, Jiong, Yu, Yong ORCID logoORCID: https://orcid.org/0000-0003-1928-2514 and Du, Jing
Cancer Research 85 (13): 2429-2447. 2 July 2025

Persistence and/or senescence: not so lasting at last?
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancer Research 85 (1): 7-9. 2 January 2025

Mouse models of human cancer.
Böck, B.C., Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Augustin, H.G.
Cancer Research 74 (17): 4671-4675. 1 September 2014

Oncogene-induced senescence: putting the brakes on tumor development.
Braig, M. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancer Research 66 (6): 2881-2884. 15 March 2006

Cancers

Evidence for recombinant GRP78, CALR, PDIA3 and GPI as mediators of genetic instability in human CD34+ cells.
Fabarius, A. ORCID logoORCID: https://orcid.org/0000-0001-5976-2876, Samra, V., Drews, O., Mörz, H., Bierbaum, M., Darwich, A. ORCID logoORCID: https://orcid.org/0000-0001-9463-9638, Weiss, C., Brendel, S., Kleiner, H., Seifarth, W., Greffrath, W., Hofmann, W.K., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Popp, H.D. ORCID logoORCID: https://orcid.org/0000-0003-0090-0204
Cancers 14 (12): 2883. 11 June 2022

DLBCL 1L-what to expect beyond R-CHOP?
Stegemann, M., Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancers 14 (6): 1453. 11 March 2022

Cell

Cellular senescence: defining a path forward.
Gorgoulis, V., Adams, P.D., Alimonti, A., Bennett, D.C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., Gil, J., Hara, E., Krizhanovsky, V., Jurk, D., Maier, A.B., Narita, M., Niedernhofer, L., Passos, J.F., Robbins, P.D., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Sedivy, J., Vougas, K., von Zglinicki, T., Zhou, D., Serrano, M. and Demaria, M.
Cell 179 (4): 813-827. 31 October 2019

Cell Death Discovery

N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness.
Dong, Hongliang, Zeng, Lili, Chen, Weiwei, Zhang, Qian, Wang, Fei, Wu, Yan, Cui, Bingjie, Qi, Jingjing, Zhang, Xin, Liu, Cuilan, Deng, Jiong, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Du, Jing ORCID logoORCID: https://orcid.org/0000-0002-2990-3575
Cell Death Discovery 9 (1): 149. 6 May 2023

Cellular and Molecular Biology Letters

lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A/RAP1 activation.
Dong, Hongliang, Xia, Yunxiu, Qi, Jingjing, Liu, Cuilan, Wang, Fei, Cui, Bingjie, Chen, Weiwei, Lv, Wenwen, Zhai, Nailiang, Deng, Jiong, Yu, Yong, Ning, Fangling, Schmitt, Clemens A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Du, Jing
Cellular and Molecular Biology Letters 30 (1): 133. 7 November 2025

Cellular and Molecular Neurobiology

Protein biomarkers in blood reflect the interrelationships between stroke outcome, inflammation, coagulation, adhesion, senescence and cancer.
Fuellen, G. ORCID logoORCID: https://orcid.org/0000-0002-4994-9829, Walter, U., Henze, L., Böhmert, J., Palmer, D., Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Rudolf, H. and Kowald, A.
Cellular and Molecular Neurobiology 43 (4): 1413-1424. May 2023

Critical Care Research and Practice

Neutropenic sepsis in the ICU: Outcome predictors in a two-phase model and microbiology findings.
Kruse, J.M., Jenning, T., Rademacher, S., Arnold, R., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Jörres, A., Enghard, P. and Oppert, M.
Critical Care Research and Practice 2016 : 8137850. 2016

Current Opinion in Genetics & Development

Chemotherapy response and resistance.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Current Opinion in Genetics & Development 13 (1): 90-96. February 2003

EMBO Journal

Transcriptional repression of NFKBIA triggers constitutive IKK- and proteasome-independent p65/RelA activation in senescence.
Kolesnichenko, M. ORCID logoORCID: https://orcid.org/0000-0001-7366-9061, Mikuda, N., Höpken, U.E. ORCID logoORCID: https://orcid.org/0000-0002-0776-4893, Kärgel, E., Uyar, B. ORCID logoORCID: https://orcid.org/0000-0002-3170-4890, Tufan, A.B. ORCID logoORCID: https://orcid.org/0000-0002-8734-9736, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Sun, W. ORCID logoORCID: https://orcid.org/0000-0001-9607-1361, Krahn, I., Schleich, K., von Hoff, L., Hinz, M. ORCID logoORCID: https://orcid.org/0000-0003-2611-4121, Willenbrock, M., Jungmann, S., Akalin, A. ORCID logoORCID: https://orcid.org/0000-0002-0468-0117, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Schmidt-Ullrich, R. ORCID logoORCID: https://orcid.org/0000-0002-2472-6530, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Scheidereit, C. ORCID logoORCID: https://orcid.org/0000-0002-0446-6129
EMBO Journal 40 (6): e104296. 15 March 2021

European Journal of Immunology

Reduced tumor-antigen density leads to PD-1/PD-L1 mediated impairment of partially exhausted CD8(+) T cells.
Kaiser, A.D., Schuster, K., Gadiot, J., Borkner, L., Daebritz, H., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Andreesen, R. and Blank, C.
European Journal of Immunology 42 (3): 662-671. March 2012

Genes & Development

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations.
Jing, H., Kase, J., Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Lenz, P., Hummel, M., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Lenz, G., Scheidereit, C. ORCID logoORCID: https://orcid.org/0000-0002-0446-6129, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931
Genes & Development 25 (20): 2137-2146. 15 October 2011

FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Bouchard, C., Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Paulus-Hock, V., Loddenkemper, C., Eilers, M. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Genes & Development 21 (21): 2775-2787. 1 November 2007

Gut

New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals.
Qi, J., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Akilli Öztürk, Ö., Holland, J.D., Besser, D. ORCID logoORCID: https://orcid.org/0000-0002-4958-9624, Fritzmann, J., Wulf-Goldenberg, A., Eckert, K., Fichtner, I. and Birchmeier, W. ORCID logoORCID: https://orcid.org/0000-0003-1173-0829
Gut 65 (10): 1690-1701. October 2016

HemaSphere

Comparing functional and genomic-based precision medicine in blood cancer patients.
Kazianka, L., Pichler, A., Agreiter, C., Rohrbeck, J., Kornauth, C., Porpaczy, E., Sillaber, C., Sperr, W.R., Gleixner, K.V., Hauswirth, A., Jäger, U., Valent, P., Jonak, C., Porkert, S., Exner, R., Willenbacher, W., Wolf, D., Neumeister, P., Prochazka, K., Deutsch, A., Greil, R., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Ristl, R., Mayerhoefer, M., Simonitsch-Klupp, I., Pemovska, T. ORCID logoORCID: https://orcid.org/0000-0003-2951-4905 and Staber, P.B.
HemaSphere 9 (4): e70129. April 2025

International Journal of Cancer

Non-invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: the DACHS study.
Zaimenko, I. ORCID logoORCID: https://orcid.org/0000-0002-4581-349X, Jaeger, C., Brenner, H., Chang-Claude, J., Hoffmeister, M., Grötzinger, C., Detjen, K., Burock, S., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Lisec, J.
International Journal of Cancer 145 (1): 221-231. 1 July 2019

International Journal of Hematologic Oncology

A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response.
Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019, Bittner, A. ORCID logoORCID: https://orcid.org/0000-0001-6434-0950, Na, I.K. ORCID logoORCID: https://orcid.org/0000-0001-9902-5424, Kase, J., Frick, M., Anagnostopoulos, I., Hummel, M. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
International Journal of Hematologic Oncology 8 (4): IJH20. 19 December 2019

Journal of Clinical Investigation

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Bonifacius, A. ORCID logoORCID: https://orcid.org/0000-0002-0112-967X, Lamottke, B., Tischer-Zimmermann, S., Schultze-Florey, R., Goudeva, L., Heuft, H.G., Arseniev, L., Beier, R., Beutel, G. ORCID logoORCID: https://orcid.org/0000-0001-6758-6104, Cario, G., Fröhlich, B., Greil, J. ORCID logoORCID: https://orcid.org/0000-0003-1821-1183, Hansmann, L. ORCID logoORCID: https://orcid.org/0000-0003-3790-0128, Hasenkamp, J., Höfs, M., Hundsdoerfer, P., Jost, E., Kafa, K., Kriege, O., Kröger, N. ORCID logoORCID: https://orcid.org/0000-0001-5103-9966, Mathas, S. ORCID logoORCID: https://orcid.org/0000-0001-9626-1413, Meisel, R. ORCID logoORCID: https://orcid.org/0000-0001-5230-0628, Nathrath, M., Putkonen, M., Ravens, S., Reinhardt, H.C., Sala, E., Sauer, M.G, Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Schroers, R. ORCID logoORCID: https://orcid.org/0000-0003-2744-5491, Steckel, N.K., Trappe, R.U. ORCID logoORCID: https://orcid.org/0000-0001-7565-7160, Verbeek, M., Wolff, D. ORCID logoORCID: https://orcid.org/0000-0001-7015-3190, Blasczyk, R. ORCID logoORCID: https://orcid.org/0000-0003-3875-3190, Eiz-Vesper, B. and Maecker-Kolhoff, B. ORCID logoORCID: https://orcid.org/0000-0001-8164-514X
Journal of Clinical Investigation 133 (12): e163548. 15 June 2023

Cellular senescence in cancer treatment: friend or foe?
Kahlem, P., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Journal of Clinical Investigation 113 (2): 169-174. January 2004

Journal of Clinical Medicine

Local and central evaluation of HER2 positivity and clinical outcome in advanced gastric and gastroesophageal cancer: results from the AGMT GASTRIC-5 Registry.
Huemer, F., Weiss, L. ORCID logoORCID: https://orcid.org/0000-0002-2174-5613, Regitnig, P. ORCID logoORCID: https://orcid.org/0000-0002-1371-1595, Winder, T., Hartmann, B., Thaler, J., Piringer, G., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Eisterer, W., Gänzer, H., Wüstner, Al., Andel, J., Jagdt, B., Ulmer, H., Greil, R. ORCID logoORCID: https://orcid.org/0000-0002-4462-3694 and Wöll, E.
Journal of Clinical Medicine 9 (4): 935. 29 March 2020

Journal of Experimental Medicine

Cellular senescence: neither irreversible nor reversible.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Journal of Experimental Medicine 221 (4): e20232136. 1 April 2024

Journal of Molecular Medicine

Non-cell-autonomous tumor suppression: oncogene-provoked apoptosis promotes tumor cell senescence via stromal crosstalk.
Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931
Journal of Molecular Medicine 89 (9): 869-875. September 2011

Apoptosis and chemoresistance in transgenic cancer models.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lowe, S.W.
Journal of Molecular Medicine 80 (3): 137-146. March 2002

Journal of Rheumatology

Inter and intraobserver variability in DePalma's classification of shoulder calcific tendinitis.
Maier, M., Maier-Bosse, T., Schulz, C.U., Steinborn, M., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Kleen, M. and Staebler, A.
Journal of Rheumatology 30 (5): 1029-1031. May 2003

Journal of Visualized Experiments

Simultaneous imaging and flow-cytometry-based detection of multiple fluorescent senescence markers in therapy-induced senescent cancer cells.
Dovjak, E., Mairhofer, M., Wöß, C., Qi, J., Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Yu, Y.
Journal of Visualized Experiments (185): e63973. 12 July 2022

Journal of the National Cancer Institute

Therapy-induced senescence: opportunities to improve anticancer therapy.
Prasanna, P.G. ORCID logoORCID: https://orcid.org/0000-0001-8386-926X, Citrin, D.E. ORCID logoORCID: https://orcid.org/0000-0002-4391-2734, Hildesheim, J., Ahmed, M.M., Venkatachalam, S., Riscuta, G., Xi, D., Zheng, G. ORCID logoORCID: https://orcid.org/0000-0002-8106-6663, van Deursen, J., Goronzy, J. ORCID logoORCID: https://orcid.org/0000-0001-7670-1856, Kron, S.J. ORCID logoORCID: https://orcid.org/0000-0003-1518-2436, Anscher, M.S., Sharpless, N.E. ORCID logoORCID: https://orcid.org/0000-0001-7078-9455, Campisi, J. ORCID logoORCID: https://orcid.org/0000-0001-6858-9462, Brown, S.L., Niedernhofer, L.J., O'Loghlen, A., Georgakilas, A.G. ORCID logoORCID: https://orcid.org/0000-0002-5971-0010, Paris, F. ORCID logoORCID: https://orcid.org/0000-0002-0176-7348, Gius, D., Gewirtz, D.A. ORCID logoORCID: https://orcid.org/0000-0003-0437-4934, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Abazeed, M.E. ORCID logoORCID: https://orcid.org/0000-0002-6614-4440, Kirkland, J.L. ORCID logoORCID: https://orcid.org/0000-0003-1676-4905, Richmond, A. ORCID logoORCID: https://orcid.org/0000-0002-9580-900X, Romesser, P.B. ORCID logoORCID: https://orcid.org/0000-0001-8268-2903, Lowe, S.W., Gil, J. ORCID logoORCID: https://orcid.org/0000-0002-4303-6260, Mendonca, M.S. ORCID logoORCID: https://orcid.org/0000-0001-9139-1964, Burma, S., Zhou, D. and Coleman, C.N.
Journal of the National Cancer Institute 113 (10): 1285-1298. October 2021

Leukemia

Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.
Arends, C.M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., Christen, F., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Pelzer, U., Sinn, M., Zemojtel, T., Ogawa, S., Märdian, S., Schreiber, A. ORCID logoORCID: https://orcid.org/0000-0003-1244-6379, Kunitz, A., Krüger, U., Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510, Mylonas, E., Frick, M. and Damm, F.
Leukemia 32 (9): 1908-1919. September 2018

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.
Young, E., Noerenberg, D., Mansouri, L., Ljungström, V., Frick, M., Sutton, L.A., Blakemore, S.J., Galan-Sousa, J., Plevova, K., Baliakas, P., Rossi, D., Clifford, R., Roos-Weil, D., Navrkalova, V., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Smedby, K.E., Juliusson, G., Giacopelli, B., Blachly, J.S., Belessi, C., Panagiotidis, P., Chiorazzi, N., Davi, F., Langerak, A.W., Oscier, D., Schuh, A., Gaidano, G., Ghia, P., Xu, W., Fan, L., Bernard, O.A., Nguyen-Khac, F., Rassenti, L., Li, J., Kipps, T.J., Stamatopoulos, K., Pospisilova, S., Zenz, T., Oakes, C.C., Strefford, J.C., Rosenquist, R. and Damm, F.
Leukemia 31 (7): 1547-1554. July 2017

Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient.
Subklewe, M., Nagy, M., Schoch, C., Jenisch, S., Siebert, R., Gesk, S., Neuhaus, P., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmidt, C.A.
Leukemia 18 (12): 2050-2053. 7 October 2004

Leukemia & Lymphoma

Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report.
Stegemann, Maike ORCID logoORCID: https://orcid.org/0009-0007-3961-9344, Macherndl-Spandl, Sigrid ORCID logoORCID: https://orcid.org/0009-0007-1247-7948, Mairhofer, Mario ORCID logoORCID: https://orcid.org/0000-0002-7218-6284, Kaltenbrunner, Sabine ORCID logoORCID: https://orcid.org/0000-0002-2794-025X, Buxhofer-Ausch, Veronika ORCID logoORCID: https://orcid.org/0000-0002-7369-9700, Clausen, Johannes ORCID logoORCID: https://orcid.org/0000-0002-2729-9706, Petzer, Andreas ORCID logoORCID: https://orcid.org/0000-0003-1595-0300 and Schmitt, Clemens A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Leukemia & Lymphoma 67 (5): 1147-1151. April 2026

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals.
Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019, Bittner, A. ORCID logoORCID: https://orcid.org/0000-0001-6434-0950, Frick, M., Kase, J., Hoffmann, J., Trenker, C., Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958, Bogner, C., Hüttmann, A., Dürig, J., Janz, M. ORCID logoORCID: https://orcid.org/0000-0002-1127-0044, Mathas, S. ORCID logoORCID: https://orcid.org/0000-0001-9626-1413, Marks, R., Krohn, U., Na, I.K. ORCID logoORCID: https://orcid.org/0000-0001-9902-5424, Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Leukemia & Lymphoma 63 (1): 84-92. January 2022

Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient.
Bittner, A. ORCID logoORCID: https://orcid.org/0000-0001-6434-0950, Radke, J., Eurich, D., Wiener, E., Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019, Anagnostopoulos, I., Na, I.K. ORCID logoORCID: https://orcid.org/0000-0001-9902-5424, Heppner, F.L., Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Leukemia & Lymphoma 62 (8): 2026-2029. August 2021

Methods in Molecular Biology

Genotoxic stress-induced senescence.
Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Methods in Molecular Biology 1896 : 93-105. 2019

Detecting markers of therapy-induced senescence in cancer cells.
Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Methods in Molecular Biology 1534 : 41-52. 2017

Molecular Cancer Therapeutics

CD20-targeting immunotherapy promotes cellular senescence in B-cell lymphoma.
Däbritz, J.H.M., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Schönlein, M., Rosenfeldt, M.T., Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Kaufmann, A.M., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Molecular Cancer Therapeutics 15 (5): 1074-1081. May 2016

Molecular Genetics & Genomic Medicine

HDAC4 mutations cause diabetes and induce β-cell FoxO1 nuclear exclusion.
Gong, M. ORCID logoORCID: https://orcid.org/0000-0001-7384-3429, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Liang, L., Vuralli, D., Froehler, S. ORCID logoORCID: https://orcid.org/0000-0001-8000-2927, Kuehnen, P. ORCID logoORCID: https://orcid.org/0000-0003-0211-176X, Du Bois, P., Zhang, J., Cao, A., Liu, Y., Hussain, K., Fielitz, J. ORCID logoORCID: https://orcid.org/0000-0001-8522-1045, Jia, S. ORCID logoORCID: https://orcid.org/0000-0001-8595-9314, Chen, W. ORCID logoORCID: https://orcid.org/0000-0003-3263-1627 and Raile, K. ORCID logoORCID: https://orcid.org/0000-0002-0842-1737
Molecular Genetics & Genomic Medicine 7 (5): e602. May 2019

Molecules and Cells

NF-κB in cellular senescence and cancer treatment.
Jing, H. and Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931
Molecules and Cells 37 (3): 189-195. 31 March 2014

Nature

Virus-induced senescence is driver and therapeutic target in COVID-19.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Trimpert, J. ORCID logoORCID: https://orcid.org/0000-0003-1616-0810, Benthani, F. ORCID logoORCID: https://orcid.org/0000-0002-3283-307X, Mairhofer, M., Richter-Pechanska, P. ORCID logoORCID: https://orcid.org/0000-0001-6727-6317, Wyler, E. ORCID logoORCID: https://orcid.org/0000-0002-9884-1806, Belenki, D. ORCID logoORCID: https://orcid.org/0000-0002-9004-9849, Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T.C. ORCID logoORCID: https://orcid.org/0000-0003-1378-4951, Dietert, K., Schotsaert, M., Martínez-Romero, C. ORCID logoORCID: https://orcid.org/0000-0001-8888-7715, Singh, G. ORCID logoORCID: https://orcid.org/0000-0003-3260-2631, Kunz, S. ORCID logoORCID: https://orcid.org/0000-0002-0131-3506, Niemeyer, D. ORCID logoORCID: https://orcid.org/0000-0002-1897-6365, Ghanem, R., Salzer, H.J.F., Paar, C., Mülleder, M., Uccellini, M., Michaelis, E.G., Khan, A., Lau, A., Schönlein, M. ORCID logoORCID: https://orcid.org/0000-0003-3156-3132, Habringer, A., Tomasits, J., Adler, J.M., Kimeswenger, S. ORCID logoORCID: https://orcid.org/0000-0002-0443-8558, Gruber, A.D. ORCID logoORCID: https://orcid.org/0000-0002-4502-0393, Hoetzenecker, W., Steinkellner, H., Purfuerst, B. ORCID logoORCID: https://orcid.org/0000-0002-9887-7577, Motz, R., Di Pierro, F., Lamprecht, B. ORCID logoORCID: https://orcid.org/0000-0003-3365-3449, Osterrieder, N., Landthaler, M. ORCID logoORCID: https://orcid.org/0000-0002-1075-8734, Drosten, C. ORCID logoORCID: https://orcid.org/0000-0001-7923-0519, García-Sastre, A. ORCID logoORCID: https://orcid.org/0000-0002-6551-1827, Langer, R., Ralser, M., Eils, R. ORCID logoORCID: https://orcid.org/0000-0002-0034-4036, Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature 599 (7884): 283-289. 11 November 2021

Senescence-associated reprogramming promotes cancer stemness.
Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076, Belenki, D. ORCID logoORCID: https://orcid.org/0000-0002-9004-9849, Däbritz, J.H.M., Zhao, Z., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Dimitrova, L., Lenze, D., Monteiro Barbosa, I.A., Mendoza-Parra, M.A., Kanashova, T. ORCID logoORCID: https://orcid.org/0000-0001-8841-5785, Metzner, M., Pardon, K., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Trumpp, A., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G. ORCID logoORCID: https://orcid.org/0000-0003-3647-8623, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature 553 (7686): 96-100. 4 January 2018

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.
Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Beuster, G., Zasada, C. ORCID logoORCID: https://orcid.org/0000-0003-1547-8317, Däbritz, J.H.M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B. ORCID logoORCID: https://orcid.org/0000-0002-9887-7577, Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958, Buck, A.K., Dörken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Willmitzer, L., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Kempa, S. ORCID logoORCID: https://orcid.org/0000-0002-0696-9299, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature 501 (7467): 421-425. 19 September 2013

Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig, M., Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Jenuwein, T. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature 436 (7051): 660-665. 4 August 2005

Nature Cancer

A cFLIP-flop switch for senolysis.
Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Cancer 3 (11): 1279-1281. November 2022

Nature Cell Biology

AP-1 imprints a reversible transcriptional programme of senescent cells.
Martínez-Zamudio, R.I. ORCID logoORCID: https://orcid.org/0000-0001-9202-4285, Roux, P.F., de Freitas, J.A.N.L.F. ORCID logoORCID: https://orcid.org/0000-0003-3689-765X, Robinson, L., Doré, G., Sun, B. ORCID logoORCID: https://orcid.org/0000-0002-8963-4100, Belenki, D. ORCID logoORCID: https://orcid.org/0000-0002-9004-9849, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Herbig, U., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Gil, J. ORCID logoORCID: https://orcid.org/0000-0002-4303-6260 and Bischof, O. ORCID logoORCID: https://orcid.org/0000-0003-2422-6277
Nature Cell Biology 22 (7): 842-855. July 2020

The dynamic nature of senescence in cancer.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Cell Biology 21 (1): 94-101. January 2019

The persistent dynamic secrets of senescence.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Cell Biology 18 (9): 913-915. September 2016

Nature Communications

Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.
Belenki, D. ORCID logoORCID: https://orcid.org/0000-0002-9004-9849, Richter-Pechanska, P. ORCID logoORCID: https://orcid.org/0000-0001-6727-6317, Shao, Z., Bhattacharya, A. ORCID logoORCID: https://orcid.org/0000-0003-3733-7670, Lau, A., de Freitas, J.A.N.L.F. ORCID logoORCID: https://orcid.org/0000-0003-3689-765X, Kandler, G., Hick, T.P., Cai, X., Scharnagl, Eva, Bittner, A. ORCID logoORCID: https://orcid.org/0000-0001-6434-0950, Schönlein, M., Kase, J., Pardon, K., Brzezicha, B., Thiessen, N., Bischof, O. ORCID logoORCID: https://orcid.org/0000-0003-2422-6277, Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Du, J., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Chapuy, B. ORCID logoORCID: https://orcid.org/0000-0002-6485-8773, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Leser, U., Scheidereit, C. ORCID logoORCID: https://orcid.org/0000-0002-0446-6129, Wolf, J. ORCID logoORCID: https://orcid.org/0000-0003-3254-5868, Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Communications 16 (1): 3079. 31 March 2025

The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke, J. ORCID logoORCID: https://orcid.org/0000-0001-9860-2007, Ishaque, N. ORCID logoORCID: https://orcid.org/0000-0002-8426-901X, Koll, R., Gu, Z., Schumann, E., Sieverling, L. ORCID logoORCID: https://orcid.org/0000-0002-0595-4976, Uhrig, S., Hübschmann, D. ORCID logoORCID: https://orcid.org/0000-0002-6041-7049, Toprak, U.H., López, C., Hostench, X.P. ORCID logoORCID: https://orcid.org/0000-0003-2089-3777, Borgoni, S., Juraeva, D. ORCID logoORCID: https://orcid.org/0000-0003-0035-3503, Pritsch, F., Paramasivam, N., Balasubramanian, G.P., Schlesner, M. ORCID logoORCID: https://orcid.org/0000-0002-5896-4086, Sahay, S., Weniger, M., Pehl, D., Radbruch, H. ORCID logoORCID: https://orcid.org/0000-0001-6941-3397, Osterloh, A., Korfel, A., Misch, M., Onken, J., Faust, K., Vajkoczy, P., Moskopp, D. ORCID logoORCID: https://orcid.org/0000-0002-4173-7653, Wang, Y., Jödicke, A., Trümper, L., Anagnostopoulos, I., Lenze, D., Küppers, R. ORCID logoORCID: https://orcid.org/0000-0002-6691-7191, Hummel, M., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Wiestler, O.D., Wolf, S., Unterberg, A., Eils, R. ORCID logoORCID: https://orcid.org/0000-0002-0034-4036, Herold-Mende, C., Brors, B. ORCID logoORCID: https://orcid.org/0000-0001-5940-3101, Siebert, R., Wiemann, S. ORCID logoORCID: https://orcid.org/0000-0003-4683-3174 and Heppner, F.L. ORCID logoORCID: https://orcid.org/0000-0001-9816-8917
Nature Communications 13 (1): 2558. 10 May 2022

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.
Brägelmann, J. ORCID logoORCID: https://orcid.org/0000-0002-1306-2169, Lorenz, C., Borchmann, S., Nishii, K., Wegner, J. ORCID logoORCID: https://orcid.org/0000-0001-8103-8040, Meder, L., Ostendorp, J., Ast, D.F., Heimsoeth, A., Nakasuka, T., Hirabae, A., Okawa, S., Dammert, M.A. ORCID logoORCID: https://orcid.org/0000-0003-4269-7822, Plenker, D. ORCID logoORCID: https://orcid.org/0000-0003-3895-4064, Klein, S., Lohneis, P. ORCID logoORCID: https://orcid.org/0000-0002-4797-0018, Gu, J., Godfrey, L.K., Forster, J., Trajkovic-Arsic, M., Zillinger, T. ORCID logoORCID: https://orcid.org/0000-0002-0866-4835, Haarmann, M., Quaas, A., Lennartz, S., Schmiel, M., D'Rozario, J. ORCID logoORCID: https://orcid.org/0000-0002-3380-4801, Thomas, E.S., Li, H. ORCID logoORCID: https://orcid.org/0000-0002-4673-1234, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, George, J. ORCID logoORCID: https://orcid.org/0000-0002-4272-3683, Thomas, R.K., von Karstedt, S. ORCID logoORCID: https://orcid.org/0000-0002-7816-5919, Hartmann, G. ORCID logoORCID: https://orcid.org/0000-0003-1021-2018, Büttner, R. ORCID logoORCID: https://orcid.org/0000-0001-8806-4786, Ullrich, R.T., Siveke, J.T. ORCID logoORCID: https://orcid.org/0000-0002-8772-4778, Ohashi, K., Schlee, M. ORCID logoORCID: https://orcid.org/0000-0003-3671-7639 and Sos, M.L. ORCID logoORCID: https://orcid.org/0000-0002-2868-100X
Nature Communications 12 (1): 5505. 17 September 2021

H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.
Schleich, K., Kase, J., Dörr, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4927-6548, Trescher, S., Bhattacharya, A. ORCID logoORCID: https://orcid.org/0000-0003-3733-7670, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Wailes, E.M., Fan, D.N.Y. ORCID logoORCID: https://orcid.org/0000-0001-6826-7076, Lohneis, P., Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Lau, A., Lenze, D., Hummel, M., Chapuy, B., Leser, U., Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128, Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Communications 11 (1): 3651. 20 July 2020

Nature Reviews Cancer

Senescence apoptosis and therapy - cutting the lifelines of cancer.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Nature Reviews Cancer 3 (4): 286-295. April 2003

Nature Reviews Clinical oncology

Senescence and cancer - role and therapeutic opportunities.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Wang, B. and Demaria, M.
Nature Reviews Clinical oncology 19 (10): 619–636. October 2022

Nature Reviews Immunology

COVID-19 and cellular senescence.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Tchkonia, T., Niedernhofer, L.J., Robbins, P.D. ORCID logoORCID: https://orcid.org/0000-0003-1068-7099, Kirkland, J.L. ORCID logoORCID: https://orcid.org/0000-0003-1676-4905 and Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931
Nature Reviews Immunology 23 (4): 251-263. April 2023

Neuro-Oncology

Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
Hu, F., a Dzaye, O.D., Hahn, A., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Scavetta, R.J., Dittmar, G. ORCID logoORCID: https://orcid.org/0000-0003-3647-8623, Kaczmarek, A.K., Dunning, K.R., Ricciardelli, C., Rinnenthal, J.L., Heppner, F.L., Lehnardt, S., Synowitz, M., Wolf, S.A. ORCID logoORCID: https://orcid.org/0000-0003-0922-8418 and Kettenmann, H. ORCID logoORCID: https://orcid.org/0000-0001-8208-0291
Neuro-Oncology 17 (2): 200-210. February 2015

Oncogene

LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Chen, W., Wang, F., Yu, X., Qi, J., Dong, H., Cui, B., Zhang, Q., Wu, Y., An, J., Ni, N., Liu, C., Han, Y., Zhang, S., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Deng, J. ORCID logoORCID: https://orcid.org/0000-0002-4489-7556, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514 and Du, J. ORCID logoORCID: https://orcid.org/0000-0002-2990-3575
Oncogene 43 (18): 1328-1340. 2 May 2024

Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.
Helmrich, A., Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, O'Brien, P., Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643, Lowe, S.W., Schroeck, E. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Oncogene 24 : 4174-4182. 1 January 2005

Oncology

Clinical outcome in patients with carcinoma of the esophagogastric junction treated with neoadjuvant radiochemotherapy or perioperative chemotherapy: a two-enter retrospective analysis.
Wundsam, H.V., Doleschal, B., Prommer, R., Venhoda, C., Schmitt, C. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Petzer, A., Metz-Gercek, S. and Rumpold, H.
Oncology 98 (10): 706-713. October 2020

Oncotarget

Decitabine inhibits T cell proliferation via a novel TET2-dependent mechanism and exerts potent protective effect in mouse auto- and allo-immunity models.
Wang, X., Wang, J., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Ma, T., Chen, P., Zhou, B. and Tao, R.
Oncotarget 8 (34): 56802-56815. 22 August 2017

PLoS Biology

The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity.
El-Athman, R., Genov, N.N., Mazuch, J., Zhang, K., Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Fuhr, L., Abreu, M., Li, Y., Wallach, T., Kramer, A., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Relógio, A. ORCID logoORCID: https://orcid.org/0000-0002-9165-2439
PLoS Biology 15 (12): e2002940. 7 December 2017

PLoS ONE

Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice.
Gerbitz, A., Sukumar, M., Helm, F., Wilke, A., Friese, C., Fahrenwaldt, C., Lehmann, F.M., Loddenkemper, C., Kammertoens, T. ORCID logoORCID: https://orcid.org/0000-0003-3309-5141, Mautner, J., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Blankenstein, T. ORCID logoORCID: https://orcid.org/0000-0002-3357-4321 and Bornkamm, G.W.
PLoS ONE 7 (3): e34552. 30 March 2012

Hypoxia-inducible factor 1α determines gastric cancer chemosensitivity via modulation of p53 and NF-κB.
Rohwer, N., Dame, C., Haugstetter, A.M., Wiedenmann, B., Detjen, K., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Cramer, T.
PLoS ONE 5 (8): e12038. 10 August 2010

Rapid Communications in Mass Spectrometry

Compound annotation in liquid chromatography/high-resolution mass spectrometry based metabolomics: robust adduct ion determination as a prerequisite to structure prediction in electrospray ionization mass spectra.
Jaeger, C. ORCID logoORCID: https://orcid.org/0000-0001-7596-6262, Méret, M., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Lisec, J.
Rapid Communications in Mass Spectrometry 31 (15): 1261-1266. 15 August 2017

Recent Results in Cancer Research

Metabolism in cancer.
Cramer, T. and Schmitt, C., eds.
Recent Results in Cancer Research, 207 . Springer. ISBN 978-3-319-42118-6 2016

Research Square

Patient-specific B-cell lymphoma modeling identifies cooperating genetic alterations and the critical influence of patient context.
Konrath, Fabian ORCID logoORCID: https://orcid.org/0000-0002-6843-6252, Denker, Sophy ORCID logoORCID: https://orcid.org/0000-0002-0736-6019, Schmitt, Clemens ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Chapuy, Björn ORCID logoORCID: https://orcid.org/0000-0002-6485-8773 and Wolf, Jana ORCID logoORCID: https://orcid.org/0000-0003-3254-5868
Research Square : rs.3.rs-9022766/v1. 12 March 2026

Seminars in Cancer Biology

The Myc/macrophage tango: Oncogene-induced senescence, Myc style.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Reimann, M. ORCID logoORCID: https://orcid.org/0000-0002-7876-0128
Seminars in Cancer Biology 21 (6): 377-384. December 2011

Theranostics

Epigenetic co-deregulation of EZH2/TET1 is a senescence-countering, actionable vulnerability in triple-negative breast cancer.
Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514, Qi, J., Xiong, J. ORCID logoORCID: https://orcid.org/0000-0002-4302-3515, Jiang, L., Cui, D., He, J., Chen, P., Li, L., Wu, C., Ma, T., Shao, S., Wang, J., Yu, D., Zhou, B., Huang, D., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Tao, R.
Theranostics 9 (3): 761-777. 24 January 2019

Therapeutic Advances in Medical Oncology

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Rinnerthaler, G., Gampenrieder, S.P. ORCID logoORCID: https://orcid.org/0000-0002-3966-1071, Petzer, A., Hubalek, M., Petru, E., Sandholzer, M., Andel, J., Balic, M., Melchardt, T., Hauser-Kronberger, C., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Ulmer, H. and Greil, R.
Therapeutic Advances in Medical Oncology 13 : 17588359211042301. 19 October 2021

Transplantation

T cell PTLD successfully treated with single-agent brentuximab vedotin first-line therapy.
Choi, M. ORCID logoORCID: https://orcid.org/0000-0002-0286-1491, Fink, S., Prasad, V., Anagnostopoulos, I., Reinke, P. and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Transplantation 100 (3): e8-e10. March 2016

Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo.
Lee, S. ORCID logoORCID: https://orcid.org/0000-0002-4614-2931, Doerken, B. ORCID logoORCID: https://orcid.org/0000-0001-7991-3643 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Transplantation 78 (3): 484-485. 15 August 2004

Trends in Cell Biology

The Senescence-Stemness Alliance - a cancer-hijacked regeneration principle.
Milanovic, M. ORCID logoORCID: https://orcid.org/0000-0003-1860-6003, Yu, Y. ORCID logoORCID: https://orcid.org/0000-0003-1928-2514 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Trends in Cell Biology 28 (12): 1049-1061. December 2018

bioRxiv

Therapy-induced senescence upregulates antigen presentation machinery and triggers anti-tumor immunity in acute myeloid leukemia.
Gilioli, D., Fusco, S., Tavella, T., Giannetti, K., Conti, A., Santoro, A., Carsana, E., Beretta, S., Schönlein, M., Gambacorta, V., Aletti, F.M., Carraba, M.G., Bonini, C., Ciceri, F., Merelli, I., Vago, L., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Di Micco, R.
bioRxiv : 2022.11.17.515658. 17 November 2022

iScience

Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients.
Mairhofer, Mario ORCID logoORCID: https://orcid.org/0000-0002-7218-6284, Kausche, Lea, Kaltenbrunner, Sabine, Pammer, Maria, Ghanem, Riad, Stegemann, Maike and Schmitt, Clemens A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
iScience 28 (11): 113727. 21 November 2025

memo: Magazine of European Medical Oncology

COVID-19: new disease mechanism is simultaneously a therapeutic target.
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 15 (2): 100-101. June 2022

ASH highlights 2019: "aggressive B-cell lymphoma".
Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 13 (3): 266-269. 20 May 2020

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network.
Greinix, H.T., Attarbaschi, A., Girschikofsky, M., Greil, R., Holter, W., Neumeister, P., Peters, C., Petzer, A., Rudzki, J., Schlenke, P., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226, Schwinger, W., Wolf, D., Worel, N. and Jaeger, U.
memo: Magazine of European Medical Oncology 13 (1): 27-31. March 2020

Editorial: critical issues in lymphoma management.
Fuchs, D. ORCID logoORCID: https://orcid.org/0000-0002-9968-1576 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 12 (1): 1. March 2019

This list was generated on Sun Jul 12 13:43:43 2026 UTC.
Open Access
MDC Library